AstraZeneca pulls cancer drug application in Europe

LONDON, Sept 21 (Reuters) - AstraZeneca has pulled

an application seeking European approval to sell its

experimental cancer drug cediranib in combination with

chemotherapy to treat ovarian cancer...

Read more